Abstract:MTSS1 (metastasis suppressor 1) is an I-BAR protein that regulates cytoskeleton dynamics through interactions with actin, Rac, and actin-associated proteins. In a prior study, we identified genetic variants in a cardiac-specific enhancer upstream of that reduce human left ventricular (LV) MTSS1 expression and associate with protection against dilated cardiomyopathy (DCM). We sought to probe these effects further using population genomics and murine models. We crossed mice with a transgenic ( ) murine model of human DCM caused by the D230N pathogenic mutation in (tropomyosin 1). In females, mice had significantly increased LV ejection fraction and reduced LV volumes relative to their counterparts, signifying partial rescue of DCM due to haploinsufficiency. No differences were observed in males. To study effects in humans, we fine-mapped the locus with 82 cardiac magnetic resonance (CMR) traits in 22,381 UK Biobank participants. enhancer variants showed interaction with biological sex in their associations with several CMR traits. After stratification by biological sex, associations with CMR traits and colocalization with expression in the Genotype-Tissue Expression (GTEx) Project were observed principally in women and were substantially weaker in men. These findings suggest sex dimorphism in the effects of MTSS1-lowering alleles, and parallel the increased LV ejection fraction and reduced LV volumes observed female mice. Together, our findings at the locus suggest a genetic basis for sex dimorphism in cardiac remodeling and motivate sex-specific study of common variants associated with cardiac traits and disease.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the sex - specific effects of down - regulated MTSS1 gene expression on dilated cardiomyopathy (DCM). Specifically, the study aims to verify whether the reduced MTSS1 expression can protect women from DCM and whether this protective effect does not exist in men. ### Research background and problems MTSS1 (metastasis suppressor 1) is an I - BAR protein that regulates cytoskeletal dynamics through interactions with actin, Rac, and actin - related proteins. Previous studies have found that genetic variations in cardiac - specific enhancers can reduce the expression of MTSS1 in the human left ventricle (LV) and are associated with protection against dilated cardiomyopathy (DCM). To further explore these effects, researchers used population genomics and in - vivo mouse models for research. ### Main research questions 1. **Gender differences**: Are there gender differences in the effects of MTSS1 down - regulation on DCM? 2. **Mechanism exploration**: How does MTSS1 down - regulation partially rescue DCM in women but not have a similar effect in men? 3. **Human data verification**: In large - scale human populations, do genetic variations at the MTSS1 locus also show similar sex - specific effects? ### Method overview - **Mouse model experiments**: By crossing Mtss1 - knockout mice with transgenic mice carrying the TPM1 D230N mutation, mice of different genotypes were generated to evaluate their cardiac function. - **Population genomics analysis**: Using data from the UK Biobank, the associations between genetic variations near the MTSS1 locus and 82 cardiac magnetic resonance (CMR) features were fine - mapped, and the co - localization of these variations with MTSS1 expression in cardiac tissue was tested. ### Key findings - **Mouse experiment results**: In female mice, the cardiac ejection fraction of Tg/Mtss1+/- mice was significantly increased, and the left ventricular volume was reduced, indicating that MTSS1 down - regulation partially rescued DCM; this phenomenon was not observed in male mice. - **Human data support**: In humans, the associations between MTSS1 enhancer variations and multiple CMR features are mainly present in women, and the associations in men are weaker, which is consistent with the mouse experiment results. ### Conclusion This study shows that MTSS1 down - regulation may have a cardioprotective effect on women but no obvious effect on men. This finding reveals the existence of sexual dimorphism in the process of cardiac remodeling and suggests that gender differences should be considered in the future to more accurately assess the risk and mechanism of heart diseases. ### Formula representation The statistical significance test results involved in the article are as follows: - Left ventricular end - systolic volume (LVESV): ColocPr = 0.993 - Left ventricular end - diastolic volume (LVEDV): ColocPr = 0.764 - Left ventricular ejection fraction (LVEF): ColocPr = 0.994 - Global left ventricular strain (Ecc_Global): ColocPr = 0.995 These results are presented in Markdown format to ensure the correctness and readability of the formulas.

Sex-Specific Effect of MTSS1 Downregulation on Dilated Cardiomyopathy

Abstract 11154: Cardioprotective Effects of Mtss1 Reduction Iin Dilated Cardiomyopathy

Abstract 13146: Cardioprotective Effects of Mtss1 Reduction in Dilated Cardiomyopathy

Reduced Expression of MTSS1 Increases Sarcomere Number and Improves Contractility in Select Forms of Monogenic DCM

Association Between SCN5A R225Q Variant and Dilated Cardiomyopathy: Potential Role of Intracellular Ph and WNT/β-catenin Pathway

Abstract 11869: Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the Multi-Ethnic Study of Atherosclerosis

Integration analysis using bioinformatics and experimental validation on cellular signalling for sex differences of hypertrophic cardiomyopathy

ZBTB17 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

Abstract P439: Harnessing Multiscale Models Of A Dilated Cardiomyopathy Mutation For Precision Medicine

Exploring the etiology of dilated cardiomyopathy using Mendelian randomization

A systematic review and meta-analysis to determine the biological sex ratio in monogenic genetic and non-genetic dilated cardiomyopathy

Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy

Transcriptomic Analysis of Dysregulated Genes of the nDNA-mtDNA Axis in a Mouse Model of Dilated Cardiomyopathy

Distinct mechanisms drive divergent phenotypes in hypertrophic and dilated cardiomyopathy associated TPM1 variants

Sex-Specific Response to A1BG Loss Results in Female Dilated Cardiomyopathy

Abstract 310: Mechanistic Insights into Duchenne Muscular Dystrophy-Associated Cardiomyopathy

MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy.

A multi-omics atlas of sex-specific differences in obstructive hypertrophic cardiomyopathy

Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic HFpEF model

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect

MYH11 rare variant augments aortic growth and induces cardiac hypertrophy and heart failure with pressure overload